Study of Pembrolizumab (MK-3475) or Placebo Given With Best Supportive Care in Asian Participants With Previously Treated Advanced Hepatocellular Carcinoma (MK-3475-394/KEYNOTE-394)
PHASE3
The purpose of this study is to determine the efficacy and safety of pembro...
Use of Nasal Nitric Oxide Testing in Improving Primary Ciliary Dyskinesia Clinical Care
N/A
this study is aiming at learning more about primary ciliary dyskinesia (PCD...
Status
Recruiting
Location
Arkansas Children's Hospital
Start Date
2021-06-14
Trial ID
NCT05287022
Substudy 02B: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With First Line (1L) Advanced Melanoma (MK-3475-02B/KEYMAKER-U02)
PHASE1
Substudy 02B is part of a larger research study where researchers are looki...
Status
Completed
Location
The Angeles Clinic and Research Institute ( Site 2009)
ChemoINTEL Assay Algorithm Development Study: In-Vitro Cytotoxic Drug Induced Apoptosis Correlation with Patient Clinical Response to Administered Chemotherapy in Patients
N/A
This is a prospective, non-randomized, observational, clinical development ...
Efficacy and Safety Study of Pembrolizumab (MK-3475) in Combination With Daratumumab in Participants With Relapsed Refractory Multiple Myeloma (MK-3475-668/KEYNOTE-668)
PHASE2
The purpose of this study is to assess the efficacy and safety of pembroliz...